STANDARD BIOTLS (LAB)
(Delayed Data from NSDQ)
$2.40 USD
-0.01 (-0.41%)
Updated May 10, 2024 04:00 PM ET
After-Market: $2.40 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for Standard BioTools Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -74.66 | -190.10 | -59.24 | -53.02 | -64.79 |
Depreciation/Amortization & Depletion | 15.95 | 15.86 | 16.69 | 18.49 | 18.18 |
Net Change from Assets/Liabilities | 1.79 | -15.48 | -19.93 | 2.41 | -13.24 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 13.63 | 100.35 | 18.42 | 16.70 | 24.64 |
Net Cash From Operating Activities | -43.29 | -89.37 | -44.06 | -15.42 | -35.21 |
Property & Equipment | -2.83 | -3.83 | -13.26 | -12.72 | -2.53 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 1.32 | 15.88 | 0.00 |
Investments | 23.07 | -84.30 | 0.00 | 36.81 | -36.77 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 20.24 | -88.13 | -11.95 | 39.98 | -39.30 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -4.59 | 225.35 | 1.49 | 22.00 | 2.13 |
Issuance (Repayment) of Debt | -2.08 | 18.16 | 9.50 | -0.68 | 1.29 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 6.84 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.14 | -12.76 | -1.87 | -0.46 | -0.63 |
Net Cash from Financing Activities | -6.81 | 230.76 | 15.96 | 20.86 | 2.79 |
Effect of Exchange Rate Changes | 0.03 | -0.40 | -0.02 | 0.39 | 0.06 |
Net Change In Cash & Equivalents | -29.83 | 52.86 | -40.07 | 45.80 | -71.67 |
Cash at Beginning of Period | 82.32 | 29.47 | 69.54 | 23.74 | 95.40 |
Cash at End of Period | 52.50 | 82.32 | 29.47 | 69.54 | 23.74 |
Diluted Net EPS | -0.94 | -2.43 | -0.78 | -0.74 | -0.97 |
Fiscal Year End for Standard BioTools Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -74.66 | -54.88 | -33.88 | -16.84 |
Depreciation/Amortization & Depletion | NA | 15.95 | 11.87 | 7.70 | 3.87 |
Net Change from Assets/Liabilities | NA | 1.79 | 3.40 | 1.71 | 1.31 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 13.63 | 10.39 | 6.67 | 3.18 |
Net Cash From Operating Activities | NA | -43.29 | -29.23 | -17.81 | -8.49 |
Property & Equipment | NA | -2.83 | -2.75 | -1.85 | -1.01 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 23.07 | 36.11 | 85.13 | 44.16 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 20.24 | 33.35 | 83.28 | 43.15 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -4.59 | -4.83 | -4.52 | -2.47 |
Issuance (Repayment) of Debt | NA | -2.08 | -0.83 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -0.14 | -0.14 | -0.13 | -0.09 |
Net Cash from Financing Activities | NA | -6.81 | -5.81 | -4.64 | -2.56 |
Effect of Exchange Rate Changes | NA | 0.03 | -0.20 | -0.05 | 0.02 |
Net Change In Cash & Equivalents | NA | -29.83 | -1.87 | 60.78 | 32.13 |
Cash at Beginning of Period | NA | 82.32 | 82.32 | 82.32 | 82.32 |
Cash at End of Period | NA | 52.50 | 80.45 | 143.10 | 114.46 |
Diluted Net EPS | NA | -0.24 | -0.27 | -0.22 | -0.21 |